Skip to main content

What the FDA labels say about taking them together

Mitoxantrone and sofosbuvir/velpatasvir/voxilaprevir

Sofosbuvir/velpatasvir/voxilaprevir's FDA label of July 14, 2025 names mitoxantrone in its drug interactions section; the mitoxantrone label PlainMeds reads does not name sofosbuvir/velpatasvir/voxilaprevir. The sofosbuvir/velpatasvir/voxilaprevir label: “Coadministration of VOSEVI with BCRP substrates is not recommended.”

Check it at the source: the mitoxantrone FDA label on DailyMed (effective April 24, 2025, Meitheal Pharmaceuticals Inc.); the sofosbuvir/velpatasvir/voxilaprevir FDA label on DailyMed (effective July 14, 2025, Gilead Sciences, Inc.).

What does the mitoxantrone label say about sofosbuvir/velpatasvir/voxilaprevir?

Mitoxantrone's label (effective April 24, 2025) does not name sofosbuvir/velpatasvir/voxilaprevir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (mitoXANTRONE), Meitheal Pharmaceuticals Inc., effective April 24, 2025 (SPL set 1634528a-30c5-4309-acc8-4c0293ae14ae), via openFDA; the full label on DailyMed

What does the sofosbuvir/velpatasvir/voxilaprevir label say about mitoxantrone?

Sofosbuvir/velpatasvir/voxilaprevir label, drug interactions

Coadministration of VOSEVI with BCRP substrates (e.g., methotrexate, mitoxantrone, imatinib, irinotecan, lapatinib, rosuvastatin, sulfasalazine, topotecan) is not recommended [see Clinical Pharmacology (12.3) ].

Source: FDA drug label (Vosevi), Gilead Sciences, Inc., effective July 14, 2025 (SPL set 17ffc094-8ca7-45d2-80d8-fd043bc9a221), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

3Mitoxantrone generic labelers
0Sofosbuvir/velpatasvir/voxilaprevir generic labelers
MitoxantroneSofosbuvir/velpatasvir/voxilaprevir
Labeled forLeukemia, lymphoma and myelomaHepatitis C
Boxed warningYesYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?